Cart
sales@molnova.com
Abacavir hydroxyacetate
CAS No. 1446418-48-9
Abacavir hydroxyacetate( —— )
Catalog No. M33097 CAS No. 1446418-48-9
Abacavir hydroxyacetate is an orally active nucleoside analog reverse transcriptase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAbacavir hydroxyacetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAbacavir hydroxyacetate is an orally active nucleoside analog reverse transcriptase inhibitor.
-
DescriptionAbacavir hydroxyacetate is an orally active inhibitor of IL-20 and PRINS. Abacavir hydroxyacetate reduces proliferation rate of skin in psoriasis as an immune modulator. Abacavir hydroxyacetate can be used for the research of inflammatory skin problems.
-
In Vitro——
-
In VivoAbacavir hydroxyacetate (10-20 mg/kg; p.o. once) effectively controls psoriasis of mice.Animal Model:6 to 8-week-old male and female SCID mice with implantation of psoriatic tissue Dosage:10 and 20 mg/kg Administration:Oral gavage; 10-20 mg/kg once Result:Decreased the concentration of PRINS and 1L-20, and reduced the lesion area of skin. Showed a better effect than methotrexate in controlling psoriasis.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1446418-48-9
-
Formula Weight344.37
-
Molecular FormulaC16H20N6O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (290.39 mM)
-
SMILESNc1nc(NC2CC2)c2ncn([C@@H]3C[C@H](COC(=O)CO)C=C3)c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Guda A, et al. Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon. Expert Opin Investig Drugs. 2018 Nov;27(11):931-939.?
molnova catalog
related products
-
Fostemsavir Tris
Fostemsavir Tris is the prodrug of BMS-626529,is a oral, safe and effective?inhibitor of HIV-1 attachment.?It inhibits human immunodeficiency virus type 1 (HIV-1) infection by binding to gp120 and interfering with the attachment of virus to CD4+ T-cells.
-
NSC-34931
A anti-HIV-1 compound that interferes with HIV-I integrase binding to viral DNA.
-
Feruloyltyramine
NTF is likely to inhibit COX enzymes, thereby suppressing P-selectin expression on platelets, is a platelet aggregation inhibitor.
